Feb 11, 2019
In this episode, Scott Visovatti, MD discusses how early treatment of patients with abnormal exercise studies can delay, or even prevent, the development of pulmonary arterial hypertension. Dr. Visovatti is an Assistant Professor of Internal Medicine in the Division of Cardiology at the University of Michigan. As a physician-scientist in their Pulmonary Hypertension Program, he cares for patients in clinic, performs clinical research that investigates the role of exercise in the diagnosis of pulmonary hypertension, and runs a basic science research lab aimed at exploring the role of purinergic signaling in the development of pulmonary arterial hypertension.
Learn more about pulmonary hypertension at www.phaware.global Never miss an episode with the phaware® podcast app. Follow us @phaware on Facebook, Twitter, Instagram, YouTube & Linkedin Engage for a cure: www.phaware.global/donate @umichmedicine @umichCVC @antidote_me @accpchest #phaware #phawareMD